Search results
Results from the WOW.Com Content Network
Ocular melanosis (OM) is a blue-gray and/or brown lesion of the conjunctiva that can be separated into benign conjunctival epithelial melanosis (BCEM) and primary acquired melanosis (PAM), of which the latter is considered a risk factor for uveal melanoma. [1]
Uveal melanoma is a type of eye cancer in the uvea of the eye. [4] It is traditionally classed as originating in the iris , choroid , and ciliary body , but can also be divided into class I (low metastatic risk) and class II (high metastatic risk). [ 4 ]
Choroidal nevus (plural: nevi) is a type of eye neoplasm that is classified under choroidal tumors as a type of benign (non-cancerous) melanocytic tumor. [1] A choroidal nevus can be described as an unambiguous pigmented blue or green-gray choroidal lesion, found at the front of the eye, around the iris, [ 2 ] or the rear end of the eye.
An eye neoplasm is a tumor of the eye. [1] A rare type of tumor, [2] eye neoplasms can affect all parts of the eye, and can either be benign or malignant , in which case it is known as eye cancer. [3] Eye cancers can be primary (starts within the eye) or metastatic cancer (spread to the eye from another organ
About 5% of Americans have a freckle in the back of their eye, known as a choroidal nevus, which is similar to a freckle or mole people have on their skin, according to the American Society of ...
Nevi are typically diagnosed clinically with the naked eye or using dermatoscopy. More advanced imaging tests are available for distinguishing melanocytic nevi from melanoma, including computerized dermoscopy and image analysis. [14] The management of nevi depends on the type of nevus and the degree of diagnostic uncertainty.
Nevi and melanomas are a group of neoplasia. Although a nevus and a melanoma are often treated as independent entities, there is evidence that a nevus can be a precursor for a melanoma. [1] Common mutations have been identified in nevi and melanomas. [2] [3] [4]
Microvascular Density in Predicting Survival of Patients with Choroidal and Ciliary Body Melanoma; Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma; Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years’ experience with beta-rays)